Nefiracetam has been used in trials studying the treatment of Alzheimer's Disease.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Hydrocodone | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Magnesium sulfate | The therapeutic efficacy of Nefiracetam can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Nefiracetam may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Mirtazapine | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Orphenadrine | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Pramipexole | Nefiracetam may increase the sedative activities of Pramipexole. |
| Ropinirole | Nefiracetam may increase the sedative activities of Ropinirole. |
| Rotigotine | Nefiracetam may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Nefiracetam. |
| Sodium oxybate | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Thalidomide | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Nefiracetam. |
| Ethanol | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Nefiracetam may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Zimelidine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Nefiracetam. |
| Indalpine | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Alaproclate. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Nefiracetam. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Nefiracetam. |
| Zopiclone | The risk or severity of adverse effects can be increased when Nefiracetam is combined with Zopiclone. |
| Botulinum toxin type B | The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Nefiracetam. |
| Botulinum toxin type A | The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Nefiracetam. |
| Baclofen | Baclofen may increase the central nervous system depressant (CNS depressant) activities of Nefiracetam. |
| Ethchlorvynol | The risk or severity of CNS depression can be increased when Ethchlorvynol is combined with Nefiracetam. |
| Succinylcholine | The risk or severity of CNS depression can be increased when Succinylcholine is combined with Nefiracetam. |
| Eletriptan | The risk or severity of CNS depression can be increased when Eletriptan is combined with Nefiracetam. |
| Enflurane | The risk or severity of CNS depression can be increased when Enflurane is combined with Nefiracetam. |
| Butabarbital | The risk or severity of CNS depression can be increased when Butabarbital is combined with Nefiracetam. |
| Butalbital | The risk or severity of CNS depression can be increased when Butalbital is combined with Nefiracetam. |
| Methysergide | The risk or severity of CNS depression can be increased when Methysergide is combined with Nefiracetam. |
| Cabergoline | The risk or severity of CNS depression can be increased when Cabergoline is combined with Nefiracetam. |
| Phenytoin | The risk or severity of CNS depression can be increased when Phenytoin is combined with Nefiracetam. |
| Topiramate | The risk or severity of CNS depression can be increased when Topiramate is combined with Nefiracetam. |
| Clemastine | The risk or severity of CNS depression can be increased when Clemastine is combined with Nefiracetam. |
| Etomidate | The risk or severity of CNS depression can be increased when Etomidate is combined with Nefiracetam. |
| Morphine | The risk or severity of CNS depression can be increased when Morphine is combined with Nefiracetam. |
| Talbutal | The risk or severity of CNS depression can be increased when Talbutal is combined with Nefiracetam. |
| Pentobarbital | The risk or severity of CNS depression can be increased when Pentobarbital is combined with Nefiracetam. |
| Zolmitriptan | The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Nefiracetam. |
| Codeine | The risk or severity of CNS depression can be increased when Codeine is combined with Nefiracetam. |
| Dihydroergotamine | The risk or severity of CNS depression can be increased when Dihydroergotamine is combined with Nefiracetam. |
| Tolcapone | The risk or severity of CNS depression can be increased when Tolcapone is combined with Nefiracetam. |
| Hydromorphone | The risk or severity of CNS depression can be increased when Hydromorphone is combined with Nefiracetam. |
| Cetirizine | The risk or severity of CNS depression can be increased when Cetirizine is combined with Nefiracetam. |
| Trimethadione | The risk or severity of CNS depression can be increased when Trimethadione is combined with Nefiracetam. |
| Chlorzoxazone | The risk or severity of CNS depression can be increased when Chlorzoxazone is combined with Nefiracetam. |
| Thiethylperazine | The risk or severity of CNS depression can be increased when Thiethylperazine is combined with Nefiracetam. |
| Palonosetron | The risk or severity of CNS depression can be increased when Palonosetron is combined with Nefiracetam. |
| Dexbrompheniramine | The risk or severity of CNS depression can be increased when Dexbrompheniramine is combined with Nefiracetam. |
| Metocurine iodide | The risk or severity of CNS depression can be increased when Metocurine iodide is combined with Nefiracetam. |
| Secobarbital | The risk or severity of CNS depression can be increased when Secobarbital is combined with Nefiracetam. |
| Methocarbamol | The risk or severity of CNS depression can be increased when Methocarbamol is combined with Nefiracetam. |
| Triprolidine | The risk or severity of CNS depression can be increased when Triprolidine is combined with Nefiracetam. |
| Meperidine | The risk or severity of CNS depression can be increased when Meperidine is combined with Nefiracetam. |
| Metharbital | The risk or severity of CNS depression can be increased when Metharbital is combined with Nefiracetam. |
| Quinine | The risk or severity of CNS depression can be increased when Quinine is combined with Nefiracetam. |
| Methohexital | The risk or severity of CNS depression can be increased when Methohexital is combined with Nefiracetam. |
| Gallamine triethiodide | The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Nefiracetam. |
| Entacapone | The risk or severity of CNS depression can be increased when Entacapone is combined with Nefiracetam. |
| Oxycodone | The risk or severity of CNS depression can be increased when Oxycodone is combined with Nefiracetam. |
| Dextromethorphan | The risk or severity of CNS depression can be increased when Dextromethorphan is combined with Nefiracetam. |
| Mephenytoin | The risk or severity of CNS depression can be increased when Mephenytoin is combined with Nefiracetam. |
| Cisatracurium | The risk or severity of CNS depression can be increased when Cisatracurium is combined with Nefiracetam. |
| Fenfluramine | The risk or severity of CNS depression can be increased when Fenfluramine is combined with Nefiracetam. |
| Mazindol | The risk or severity of CNS depression can be increased when Mazindol is combined with Nefiracetam. |
| Fluticasone propionate | The risk or severity of CNS depression can be increased when Fluticasone propionate is combined with Nefiracetam. |
| Lisuride | The risk or severity of CNS depression can be increased when Lisuride is combined with Nefiracetam. |
| Ethosuximide | The risk or severity of CNS depression can be increased when Ethosuximide is combined with Nefiracetam. |
| Thiopental | The risk or severity of CNS depression can be increased when Thiopental is combined with Nefiracetam. |
| Cisapride | The risk or severity of CNS depression can be increased when Cisapride is combined with Nefiracetam. |
| Butorphanol | The risk or severity of CNS depression can be increased when Butorphanol is combined with Nefiracetam. |